Skip to Main Content

Illumina Inc

ILMN Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ILMN by members of U.S. Congress

Politician Type Traded
Michael C. Burgess House / R Sale $15,001 - $50,000 Sep. 03, 2024
Michael C. Burgess House / R Sale $15,001 - $50,000 Aug. 30, 2024
Thomas H. Kean, Jr. House / R Purchase $1,001 - $15,000 Apr. 19, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Mar. 11, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Mar. 11, 2024
Michael C. Burgess House / R Purchase $15,001 - $50,000 Feb. 12, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Feb. 12, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Feb. 12, 2024
Michael C. Burgess House / R Purchase $1,001 - $15,000 Jan. 02, 2024
Michael C. Burgess House / R Purchase $15,001 - $50,000 Jan. 02, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Jan. 02, 2024
Kathy E. Manning House / D Sale $15,001 - $50,000 Jun. 10, 2022
Donald S. Beyer, Jr. House / D Sale $15,001 - $50,000 Feb. 28, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Dec. 01, 2021
Kathy E. Manning House / D Purchase $1,001 - $15,000 Oct. 26, 2021
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Sep. 17, 2021
Kathy E. Manning House / D Purchase $1,001 - $15,000 Aug. 25, 2021
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 May. 06, 2021
Kathy E. Manning House / D Sale $1,001 - $15,000 Feb. 24, 2021
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov. 17, 2020
Josh Gottheimer House / D Sale $1,001 - $15,000 Nov. 06, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Aug. 27, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Jul. 14, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 May. 01, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Apr. 27, 2020
Sheldon Whitehouse Senate / D Sale (Full) $1,001 - $15,000 Mar. 11, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Feb. 14, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Jan. 27, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Jan. 10, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Dec. 23, 2019
John B. Larson House / D Sale $1,001 - $15,000 Dec. 18, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Dec. 10, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov. 25, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov. 19, 2019
Josh Gottheimer House / D Sale $1,001 - $15,000 Sep. 11, 2019
Susan A. Davis House / D Purchase $15,001 - $50,000 Jan. 11, 2019
Sheldon Whitehouse Senate / D Purchase $1,001 - $15,000 Dec. 28, 2018
Josh Gottheimer House / D Purchase $1,001 - $15,000 Oct. 24, 2018
Josh Gottheimer House / D Sale $1,001 - $15,000 Jul. 24, 2017
K. Michael Conaway House / R Purchase $1,001 - $15,000 Feb. 09, 2015
Thomas MacArthur House / R Sale $1,001 - $15,000 Jan. 27, 2015
ILMN Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
ILMN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ILMN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by ILMN's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

  • $120,000 Apr 12, 2025 Issue: Manufacturing Energy/Nuclear Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $400,000 Jan 21, 2025 Issue: Budget/Appropriations Health Issues Defense
  • $280,000 Dec 12, 2024 Issue: Budget/Appropriations Defense Health Issues
  • $270,000 Jul 22, 2024 Issue: Defense Trade (domestic/foreign) Health Issues
  • $380,000 Apr 22, 2024 Issue: Defense Trade (domestic/foreign) Health Issues
  • $510,000 Jan 22, 2024 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
  • $420,000 Oct 20, 2023 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
  • $1,460,000 Jul 20, 2023 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
  • $1,300,000 Jan 20, 2023 Issue: Trade (domestic/foreign) Government Issues Health Issues
  • $1,380,000 Oct 20, 2022 Issue: Trade (domestic/foreign) Government Issues Health Issues
  • $1,690,000 Jul 20, 2022 Issue: Trade (domestic/foreign) Government Issues Health Issues
  • $1,960,000 Apr 20, 2022 Issue: Government Issues Health Issues
  • $820,000 Jan 20, 2022 Issue: Government Issues
  • $10,000 Jan 20, 2022 Issue: Government Issues
  • $60,000 Jan 20, 2022 Issue: Health Issues
  • $50,000 Jan 20, 2022 Issue: None
  • $40,000 Jan 20, 2022 Issue: Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues
  • $50,000 Jan 20, 2022 Issue: Health Issues
  • $60,000 Jan 19, 2022 Issue: Health Issues
  • $320,000 Jan 19, 2022 Issue: Health Issues Government Issues
  • $10,000 Oct 28, 2021 Issue: Government Issues
  • $920,000 Oct 21, 2021 Issue: Government Issues
  • $60,000 Oct 20, 2021 Issue: Health Issues
  • $50,000 Oct 20, 2021 Issue: None
  • $40,000 Oct 20, 2021 Issue: Medicare/Medicaid Health Issues Labor Issues/Antitrust/Workplace
  • $10,000 Oct 19, 2021 Issue: Government Issues
  • $50,000 Oct 19, 2021 Issue: Health Issues
  • $375,000 Oct 18, 2021 Issue: Health Issues Government Issues
  • $20,000 Jul 29, 2021 Issue: Health Issues
  • $60,000 Jul 20, 2021 Issue: Health Issues Labor Issues/Antitrust/Workplace
  • $40,000 Jul 20, 2021 Issue: Labor Issues/Antitrust/Workplace Health Issues Veterans Medicare/Medicaid
  • $40,000 Jul 20, 2021 Issue: Government Issues
  • $150,000 Jul 19, 2021 Issue: Health Issues Government Issues
  • $50,000 Jul 19, 2021 Issue: Trade (domestic/foreign)
  • $290,000 Apr 20, 2021 Issue: None
  • $270,000 Jan 21, 2021 Issue: None
  • $270,000 Oct 20, 2020 Issue: None
  • $170,000 Jul 20, 2020 Issue: None
  • $180,000 Apr 20, 2020 Issue: HEALTH ISSUES
  • $190,000 Jan 21, 2020 Issue: None
  • $160,000 Oct 21, 2019 Issue: Budget/Appropriations Health Issues
  • $160,000 Jul 22, 2019 Issue: Budget/Appropriations Health Issues
  • $130,000 Apr 22, 2019 Issue: Health Issues Budget/Appropriations
  • $60,000 Jan 22, 2019 Issue: Health Issues
  • $60,000 Oct 22, 2018 Issue: Health Issues
  • $70,000 Jul 20, 2018 Issue: Health Issues
  • $100,000 Apr 20, 2018 Issue: Medicare/Medicaid Budget/Appropriations
  • $50,000 Jan 19, 2018 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Budget/Appropriations
  • $50,000 Oct 20, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Budget/Appropriations
  • $50,000 Jul 20, 2017 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid
  • $40,000 Apr 18, 2017 Issue: Medical/Disease Research/Clinical Labs
  • $45,000 Jan 13, 2017 Issue: Health Issues
  • $45,000 Oct 19, 2016 Issue: Health Issues
  • $60,000 Jul 20, 2016 Issue: Health Issues
  • $90,000 Apr 20, 2016 Issue: Health Issues
  • $20,000 Jan 20, 2016 Issue: Health Issues
  • $40,000 Jan 18, 2013 Issue: Homeland Security Science/Technology Defense

Estimated quarterly lobbying spending

ILMN Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ILMN Income Statement
ILMN Balance Sheet
ILMN Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Deep learning-based root cause analysis of process cycle images Apr. 08, 2025
  • Patent Title: Display screen portion with icon Apr. 08, 2025
  • Patent Title: Method for administering a cancer treatment Apr. 01, 2025
  • Patent Title: Image sensor structures and related methods Apr. 01, 2025
  • Patent Title: Reagent cartridge Apr. 01, 2025
  • Patent Title: Limit of detection based quality control metric Mar. 25, 2025
  • Patent Title: Flowcell cartridge with floating seal bracket Mar. 18, 2025
  • Patent Title: Catalytically active substances Mar. 18, 2025
  • Patent Title: Compositions and methods for improving sample identification in indexed nucleic acid libraries Mar. 11, 2025
  • Patent Title: Sensors having integrated protection circuitry Mar. 04, 2025
  • Patent Title: Multiplexing of an active sensor detector using structured illumination Mar. 04, 2025
  • Patent Title: Tiered ligation oligos Mar. 04, 2025
  • Patent Title: Temperature-controllable reagent cartridge and temperature control system for the same Mar. 04, 2025
  • Patent Title: Flow cell with enhanced well imaging resolution Mar. 04, 2025
  • Patent Title: Reagent cartridge Mar. 04, 2025
  • Patent Title: Temporary cloud provider credentials via secure discovery framework Feb. 25, 2025
  • Patent Title: Base calling using convolution Feb. 25, 2025
  • Patent Title: Tagmentation using immobilized transposomes with linkers Feb. 25, 2025
  • Patent Title: Tube strip Feb. 25, 2025
  • Patent Title: Systems and methods for grouping and collapsing sequencing reads Feb. 18, 2025
  • Patent Title: Methods and compositions for preparing nucleic acid libraries Feb. 18, 2025
  • Patent Title: Systems and related sample loading manifold assemblies Feb. 18, 2025
  • Patent Title: Identifying nucleotides by determining phasing Feb. 11, 2025
  • Patent Title: Display screen or portion thereof with transitional graphical user interface Feb. 11, 2025
  • Patent Title: Deep learning-based variant classifier Feb. 04, 2025
  • Patent Title: Artificial intelligence-based quality scoring Feb. 04, 2025
  • Patent Title: Artificial intelligence-based analysis of protein three-dimensional (3d) structures Feb. 04, 2025
  • Patent Title: Methods and systems to correct crosstalk in illumination emitted from reaction sites Feb. 04, 2025
  • Patent Title: Inter-cluster intensity variation correction and base calling Feb. 04, 2025
  • Patent Title: Tenant-aware distributed application authentication Jan. 28, 2025
  • Patent Title: Actuation systems and methods Jan. 28, 2025
  • Patent Title: Generating nucleic acids with modified bases using recombinant terminal deoxynucleotidyl transferase Jan. 28, 2025
  • Patent Title: Display screen or portion thereof with transitional graphical user interface Jan. 28, 2025
  • Patent Title: Apparatus and method of estimating values from images Jan. 21, 2025
  • Patent Title: Catalyst-free surface functionalization and polymer grafting Jan. 21, 2025
  • Patent Title: System and method for storage Jan. 21, 2025
  • Patent Title: Methods and compositions for single cell genomics Jan. 14, 2025
  • Patent Title: Light detection devices with protective liner and methods related to same Jan. 07, 2025
  • Patent Title: Fluid management system and method Jan. 07, 2025
  • Patent Title: Compositions and methods for making controls for sequence-based genetic testing Jan. 07, 2025
  • Patent Title: Methods and devices for mixing in a microfluidic system Jan. 07, 2025
  • Patent Title: Biosensors for biological or chemical analysis and systems and methods for same Dec. 31, 2024
  • Patent Title: Transposase compositions for reduction of insertion bias Dec. 31, 2024
  • Patent Title: Systems and methods for biochemical analysis including a base instrument and a removable cartridge Dec. 31, 2024
  • Patent Title: Multi-version processing using a monitor subsystem Dec. 24, 2024
  • Patent Title: Manufacturing a flowcell with a planar waveguide Dec. 24, 2024
  • Patent Title: Flow cells Dec. 24, 2024
  • Patent Title: Buffer receptacle Dec. 24, 2024
  • Patent Title: Fluidic flow channel over active surface of a die Dec. 10, 2024
  • Patent Title: Splicing site classification using neural networks Dec. 10, 2024
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

ILMN News

Recent insights relating to ILMN

CNBC Recommendations

Recent picks made for ILMN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ILMN

ILMN Analyst Ratings

ILMN Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ILMN Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ILMN stock a Buy, Sell, or Hold?

  • What is the price target for $ILMN stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ILMN Top Shareholders
Shareholder
Shares Held
ILMN Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ILMN stock?

  • Who owns the most shares of $ILMN stock?

  • What funds own $ILMN stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ILMN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ILMN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top